Driving potent neutralization of a SARS-CoV-2 Variant of Concern with a heterotypic boost
The emergence of SARS-CoV-2 Variants of Concern (VOCs) with mutations in key neutralizing antibody epitopes threatens to undermine vaccines developed against the pandemic founder variant (Wu-Hu-1). Widespread vaccine rollout and continued transmission are creating a population that has antibody responses of varying potency to Wu-Hu-1. Against this background, it is critical to assess the outcomes of subsequent immunization with variant antigens. It is not yet known whether heterotypic vaccine boosts would be compromised by original antigenic sin, where pre-existing responses to a prior variant dampen responses to a new one, or whether the primed memory B cell repertoire would bridge the gap between Wu-Hu-1 and VOCs. Here, we show that a single adjuvanted dose of receptor binding domain (RBD) protein from VOC 501Y.V2 (B.1.351) drives an extremely potent neutralizing antibody response capable of cross-neutralizing both Wu-Hu-1 and 501Y.V2 in rhesus macaques previously immunized with Wu-Hu-1 spike protein. Passive immunization with plasma sampled following this boost protected K18-hACE2 mice from lethal challenge with a 501Y.V2 clinical isolate, whereas only partial protection was afforded by plasma sampled after two Wu-Hu-1 spike immunizations..
Media Type: |
|
---|
Year of Publication: |
2024 |
---|---|
Publication: |
2024 |
Contained In: |
bioRxiv.org - (2024) vom: 06. Aug. To Main Record - year:2024 |
---|
Language: |
English |
---|
Contributors: |
Sheward, Daniel J. [Author] |
---|
Links: |
Volltext [kostenfrei] |
---|
Keywords: |
---|
doi: |
10.1101/2021.04.03.438330 |
---|
funding: |
|
---|---|
Supporting institution / Project title: |
|
PPN (Catalogue-ID): |
XBI020290136 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | XBI020290136 | ||
003 | DE-627 | ||
005 | 20240807133802.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210406s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1101/2021.04.03.438330 |2 doi | |
035 | |a (DE-627)XBI020290136 | ||
035 | |a (biorXiv)10.1101/2021.04.03.438330 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Sheward, Daniel J. |e verfasserin |4 aut | |
245 | 1 | 0 | |a Driving potent neutralization of a SARS-CoV-2 Variant of Concern with a heterotypic boost |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a The emergence of SARS-CoV-2 Variants of Concern (VOCs) with mutations in key neutralizing antibody epitopes threatens to undermine vaccines developed against the pandemic founder variant (Wu-Hu-1). Widespread vaccine rollout and continued transmission are creating a population that has antibody responses of varying potency to Wu-Hu-1. Against this background, it is critical to assess the outcomes of subsequent immunization with variant antigens. It is not yet known whether heterotypic vaccine boosts would be compromised by original antigenic sin, where pre-existing responses to a prior variant dampen responses to a new one, or whether the primed memory B cell repertoire would bridge the gap between Wu-Hu-1 and VOCs. Here, we show that a single adjuvanted dose of receptor binding domain (RBD) protein from VOC 501Y.V2 (B.1.351) drives an extremely potent neutralizing antibody response capable of cross-neutralizing both Wu-Hu-1 and 501Y.V2 in rhesus macaques previously immunized with Wu-Hu-1 spike protein. Passive immunization with plasma sampled following this boost protected K18-hACE2 mice from lethal challenge with a 501Y.V2 clinical isolate, whereas only partial protection was afforded by plasma sampled after two Wu-Hu-1 spike immunizations. | ||
650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
700 | 1 | |a Mandolesi, Marco |e verfasserin |4 aut | |
700 | 1 | |a Urgard, Egon |e verfasserin |4 aut | |
700 | 1 | |a Kim, Changil |e verfasserin |4 aut | |
700 | 1 | |a Hanke, Leo |e verfasserin |4 aut | |
700 | 1 | |a Vidakovics, Laura Perez |e verfasserin |4 aut | |
700 | 1 | |a Pankow, Alec |e verfasserin |4 aut | |
700 | 1 | |a Smith, Natalie L. |e verfasserin |4 aut | |
700 | 1 | |a Dopico, Xaquin Castro |e verfasserin |4 aut | |
700 | 1 | |a McInerney, Gerald |e verfasserin |4 aut | |
700 | 1 | |a Coquet, Jonathan M. |e verfasserin |4 aut | |
700 | 1 | |a Hedestam, Gunilla B. Karlsson |e verfasserin |4 aut | |
700 | 1 | |a Murrell, Ben |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t bioRxiv.org |g (2024) vom: 06. Aug. |
773 | 1 | 8 | |g year:2024 |g day:06 |g month:08 |
856 | 4 | 0 | |u http://dx.doi.org/10.1101/2021.04.03.438330 |x 0 |z kostenfrei |3 Volltext |
912 | |a SYSFLAG_0 | ||
912 | |a GBV_XBI | ||
951 | |a AR | ||
952 | |j 2024 |b 06 |c 08 |